Neuronetics (STIM): CFO received 500K shares

500K

Shares

Traded

Jul 23, 2026

Filed

Jul 23, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jun 16, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On June 16, 2026, the board of directors of the Company (the “Board”) promoted Cory Anderson from the position of Senior Vice President, Chief Technology Officer to the position of Executive Vice President, General Manager of Greenbrook effective July 1, 2026 (the “Anderson Promotion Date”).”
2. Jul 9, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On July 17, 2026, Neuronetics, Inc. (the “Company”) and W. Andrew Macan, who has served as Executive Vice President, Chief Legal Officer, and Corporate Secretary and in various other similar capacities since January 21, 2020, entered into a Separation Agreement (the “Separation Agreement”).”
3. Jul 14, 2026Insider10% owner purchased ~$62K of STIM shares in the open market

What came next

1. Aug 11, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
2. Aug 11, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On August 11, 2026, in connection with Mr. Naor’s appointment (as described below), Francis X. Brown III’s appointment as Neuronetics, Inc.’s (the “Company”) interim principal financial and accounting officer ended.”
3. Aug 13, 2026Insider10% owner sold ~$321 of STIM shares in the open market
4. Aug 14, 2026Insider10% owner purchased ~$44K of STIM shares in the open market
5. Aug 24, 2026FDARecall: NeuroStar Advanced Therapy System. Contains the NeuroStar HP Coil Assembly Part Number 81-01000-200. Affects the below NeuroStar Advanced Therapy Systems: 1. N…
6. Oct 30, 2026Insider · 5 days before results10% owner purchased ~$41K of STIM shares in the open market
7. Nov 4, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
8. Nov 6, 2026Insider10% owner sold ~$599K of STIM shares in the open market
9. Nov 9, 2026Insider · 1 personInsiders: 1 purchase (~$80K), 1 sale (~$214K)
10. Nov 10, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
11. Nov 11, 2026Insider10% owner sold ~$140K of STIM shares in the open market
12. Nov 12, 2026Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
13. Nov 12, 2026Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
14. Nov 12, 2026Insider10% owner sold ~$1.01M of STIM shares in the open market
15. Nov 13, 2026Insider10% owner sold ~$2.52M of STIM shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Neuronetics

For Neuronetics, OQRO holds 10 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its STIM page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Neuronetics

• SEC Form 4Nov 14, 2026
• SEC Form 4Nov 14, 2026
• SEC Form 4Nov 14, 2026
• SEC Form 4Nov 14, 2026
• SEC Form 4Nov 14, 2026
• SEC Form 4Nov 14, 2026

Everything OQRO holds on this company is on its STIM page.